Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

Henrik Vitus Bering Laursen; Charles Vesteghem; Mia Sommer; Marlene Maria Nielsen; Karen Dybkær; Tarec El-Galaly; Hans Erik Johnsen; Lars Holger Ehlers; Martin Bøgsted

doi:10.1111/bcpt.13020

Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

Henrik Vitus Bering Laursen, Charles Vesteghem, Mia Sommer, Marlene Maria Nielsen, Karen Dybkær, Tarec El-Galaly, Hans Erik Johnsen, Lars Holger Ehlers, Martin Bøgsted

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

210 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	NorPM-P22
Bogserie	Basic & Clinical Pharmacology & Toxicology
Vol/bind	123
Udgave nummer	Suppl. 1
Sider (fra-til)	9
ISSN	1742-7843
DOI	https://doi.org/10.1111/bcpt.13020
Status	Udgivet - maj 2018
Begivenhed	First Nordic conference on Personalized Medicine - Nyborg, Danmark Varighed: 30 maj 2018 → 1 jun. 2018 Konferencens nummer: 1 http://www.norpm2018.com/

Konference

Konference	First Nordic conference on Personalized Medicine
Nummer	1
Land/Område	Danmark
By	Nyborg
Periode	30/05/2018 → 01/06/2018
Internetadresse	http://www.norpm2018.com/

Adgang til dokumentet

10.1111/bcpt.13020

NorPM-148-preview-2

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

1 Poster

Methodological challenges for the valuation of drug related treatment costs for relapsing haematological cancer patients
Laursen, H. V. B., Vesteghem, C., Sommer, M., Nielsen, M. M., Dybkær, K., El-Galaly, T., Johnsen, H. E., Ehlers, L. H. & Bøgsted, M., 28 maj 2018.
Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning

Citationsformater

Laursen, H. V. B., Vesteghem, C., Sommer, M., Nielsen, M. M., Dybkær, K., El-Galaly, T., Johnsen, H. E., Ehlers, L. H., & Bøgsted, M. (2018). Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients. Basic & Clinical Pharmacology & Toxicology, 123(Suppl. 1), 9. Artikel NorPM-P22. https://doi.org/10.1111/bcpt.13020

@article{9bf3ccd1f9f14043b9699b0a289a8a3a,

title = "Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients",

author = "Laursen, {Henrik Vitus Bering} and Charles Vesteghem and Mia Sommer and Nielsen, {Marlene Maria} and Karen Dybk{\ae}r and Tarec El-Galaly and Johnsen, {Hans Erik} and Ehlers, {Lars Holger} and Martin B{\o}gsted",

year = "2018",

month = may,

doi = "10.1111/bcpt.13020",

language = "English",

volume = "123",

pages = "9",

journal = "Basic & Clinical Pharmacology & Toxicology",

issn = "1742-7843",

publisher = "Wiley-Blackwell",

number = "Suppl. 1",

note = "First Nordic conference on Personalized Medicine ; Conference date: 30-05-2018 Through 01-06-2018",

url = "http://www.norpm2018.com/",

}

Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients. / Laursen, Henrik Vitus Bering ; Vesteghem, Charles; Sommer, Mia et al.
I: Basic & Clinical Pharmacology & Toxicology, Bind 123, Nr. Suppl. 1, NorPM-P22, 05.2018, s. 9.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

TY - ABST

T1 - Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

AU - Laursen, Henrik Vitus Bering

AU - Vesteghem, Charles

AU - Sommer, Mia

AU - Nielsen, Marlene Maria

AU - Dybkær, Karen

AU - El-Galaly, Tarec

AU - Johnsen, Hans Erik

AU - Ehlers, Lars Holger

AU - Bøgsted, Martin

N1 - Conference code: 1

PY - 2018/5

Y1 - 2018/5

U2 - 10.1111/bcpt.13020

DO - 10.1111/bcpt.13020

M3 - Conference abstract in journal

SN - 1742-7843

VL - 123

SP - 9

JO - Basic & Clinical Pharmacology & Toxicology

JF - Basic & Clinical Pharmacology & Toxicology

IS - Suppl. 1

M1 - NorPM-P22

T2 - First Nordic conference on Personalized Medicine

Y2 - 30 May 2018 through 1 June 2018

ER -

Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

Konference

Adgang til dokumentet

AUB Link

Publikation

Methodological challenges for the valuation of drug related treatment costs for relapsing haematological cancer patients

Citationsformater